Authors: BOIVIN JF HUTCHISON GB ZAUBER AG BERNSTEIN L DAVIS FG MICHEL RP ZANKE B TAN CTC FULLER LM MAUCH P ULTMANN JE

Citation: Jf. Boivin et al., INCIDENCE OF 2ND CANCERS IN PATIENTS TREATED FOR HODGKINS-DISEASE, Journal of the National Cancer Institute, 87(10), 1995, pp. 732-741

Authors: TAN CTC WOLLNER N TRIPPETT T GOKER E TONG WPY KHERADPOUR A MEYERS PA VANSYCKLE KM GUARINO L ELISSEYEFF Y BERTINO JR

Citation: Ctc. Tan et al., PHARMACOLOGICAL-GUIDED TRIAL OF SEQUENTIAL METHOTREXATE AND THIOGUANINE IN CHILDREN WITH ADVANCED MALIGNANCIES, Journal of clinical oncology, 12(9), 1994, pp. 1955-1962

Authors: WAYNE AS TAN CTC ARCECI RJ BARR R HURWITZ CA PITEL PA WEINSTEIN HJ FAVARA BE

Citation: As. Wayne et al., 2-CHLORODEOXYADENOSINE (2CDA) FOR DISORDERS OF MONO-HISTIOCYTIC (MO HI) LINEAGE/, Blood, 84(10), 1994, pp. 10000057-10000057

Authors: TAN CTC GUARINO L TONG WP WOLLNER N FINLAY J MEYERS PA STEINHERZ PG GHAVIMI F WONG ET

Citation: Ctc. Tan et al., CLINICAL AND PHARMACOLOGICAL STUDIES OF 2-CHLORODEOXYADENOSINE (2-CDA) IN CHILDREN WITH ADVANCED HEMATOLOGIC MALIGNANCIES AND SOLID TUMORS, Blood, 84(10), 1994, pp. 10000302-10000302